Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06045936 · ClinicalTrials.gov registry record · Phase 4
A Study of Contralateral Limb Block
A Phase 4 study of Limb Pain, Phantom, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06045936 is a Phase 4 study of Limb Pain, Phantom that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06045936, a Phase 4 study of Limb Pain, Phantom, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to determine if an anesthetic like Lidocaine, may be effective when injected around the sciatic nerve of the intact limb in patients with limb loss pain on the contralateral side.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Lidocaine
Study Locations (1)
Minnesota
- Mayo Clinic Health System - Mankato - Mankato
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06045936
The ClinicalTrials.gov registry entry for NCT06045936 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Limb Pain, Phantom appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06045936 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06045936 about?
NCT06045936 is a clinical study titled "A Study of Contralateral Limb Block". This research is being done to determine if an anesthetic like Lidocaine, may be effective when injected around the sciatic nerve of the intact limb in patients with limb loss pain on the contralateral side.
What is the current status of trial NCT06045936?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2024-06-18. Estimated completion is 2026-12.
What conditions does trial NCT06045936 study?
This clinical trial studies the following conditions: Limb Pain, Phantom.
What interventions are being tested in trial NCT06045936?
The interventions under investigation include: Placebo (DRUG), Lidocaine (DRUG).
Who is sponsoring clinical trial NCT06045936?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06045936 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Limb Pain, Phantom
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.